Location: Perth, Bundaberg
Clinical trials
At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.
To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Location: Melbourne, Mulgrave, Brisbane
To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.
Location: Brisbane
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Location: Newcastle , Perth, Brisbane, Bundaberg
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Location: Melbourne , Frankston
The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.
Location: Newcastle
To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.
Location: Newcastle , Perth
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Location: Newcastle , Brisbane, Frankston, Melbourne
To evaluate a new valve in patients with severe mitral regurgitation
Location: Adelaide, Brisbane, Melbourne, Perth
To evaluate a new heart failure sensing device in patients with heart failure
Location: Brisbane
To evaluate a new medication for the treatment of recurrent pericarditis.
Location: Melbourne, Brisbane
To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients
Location: Brisbane, Joondalup
To evaluate a new valve in patients with severe mitral regurgitation.
Location: Adelaide, Brisbane, Melbourne, Perth
To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.
Location: Adelaide, Brisbane, Perth, Bundaberg
Clinical Trials
At GenesisCare, we challenge ourselves every day to find new and better ways to treat illness and disease and deliver better outcomes for our patients.
Type 2 Diabetes
SURPASS-2
To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes
Joondalup – Shenton House (Cardiology)
Level 3, Shenton House, 57 Shenton Avenue, Joondalup, WA 6027
Type 2 Diabetes
SURPASS-2
To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes
St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150
Type 2 Diabetes
SURPASS-2
To evaluate and compare two medications as add-on therapy to metformin for the treatment of Type 2 Diabetes
Friendly Society Private Hospital (FSPH) Bundaberg
Floor 1, 19-23 Bingera Street, Bundaberg QLD 4670
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Health and Wellness Centre Level 1, Suites 8-10, 20 Scholar Drive, Bundoora, VIC, 3083
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Mulgrave Private Hospital, Suite 8, Churchill Consulting Suites, Blanton Drive, Mulgrave, VIC, 3170
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Unit 2 / 11 Gloucester Avenue, Berwick VIC 3806
Cardio-Oncology
SUCCOUR MRI SUB-STUDY
To evaluate if treatment with two cardioprotective medications reduces the risk of developing heart failure in participants currently undergoing chemotherapy
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Heart Failure
HEART-FID
To evaluate a new medication for the treatment of patients in heart failure with a reduced ejection fraction and with iron deficiency.
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Mater Hospital, Sydney (Oncology)
The Mater Hospital, 25 Rocklands road, North Sydney, NSW
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
24 Salvado Road, Wembley WA, Australia
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Joondalup – Shenton House (Oncology)
Shenton House, Level 3, 57 Shenton Avenue, Joondalup, WA 6027
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Wesley Medical Centre (Oncology)
The Wesley Medical Centre, 1/40 Chasely St Auchenflower, Brisbane, QLD, 4066
Skin Registry
NDROR
To collect data to evaluate specified outcomes for patients undergoing radiotherapy for skin cancer and inflammatory skin conditions
Bundaberg, Mater Hospital (Oncology), 313 Bourbong Street, Bundaberg, QLD, 4670
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East VIC 3135
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Frankston Private Hospital, 5 Susono Way, Frankston VIC, 3199
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Epping Medical Centre, Ground Floor, 230 Cooper Street, Epping, VIC, 3076
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
Western Private Hospital, 1 Marion Street, Footscray, VIC 3011
Prostate Cancer
IMPPORT
The purpose of this study is to see whether the use of a particular type of PET scan will improve detection rates of cancer and improve treatment management.
St Vincent's Hospital, Basement Level, Building C, 41 Victoria Parade, Fitzroy, VIC, 3065
Brain Cancer
GBM001
The purpose of this project is to measure the uptake of a new type of Positron Emission Tomography (PET) scan (using Ga68-PSMA) in relapsed glioblastoma. We would also like to examine if standard and new x-ray techniques such as PET can be used to predict the behaviour of the cancer. This will allow us to understand if this type of scan gives a clearer image of the tumour when compared to standard scanning.
Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290
Early Breast Cancer
POSNOC
To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.
Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290
Early Breast Cancer
POSNOC
To assess whether adjuvant therapy alone is no worse than adjuvant therapy plus axillary treatment, in terms of axillary recurrence within 5 years.
Discovery Way Murdoch University, Murdoch WA 6150, Australia
Early Breast Cancer
EXPERT
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Lake Macquarie Private Hospital, 36 Pacific Highway, Gateshead, NSW, 2290
Early Breast Cancer
EXPERT
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Wesley Medical Centre (Oncology)
The Wesley Medical Centre, 1/40 Chasely St Auchenflower, Brisbane, QLD, 4066
Early Breast Cancer
EXPERT
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Frankston Private Hospital, 5 Susono Way, Frankston VIC, 3199
Early Breast Cancer
EXPERT
A unique opportunity to improve personalised use of radiation therapy in patients with early breast cancer according to their individual risks of local recurrence
Ringwood Private Hospital, 36 Mount Dandenong Road, Ringwood East VIC 3135
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
St Andrew's Medical Centre Clinic, Level 2. 321 South Terrace, Adelaide, SA 5000
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
284 Kensington Road, Leabrook, SA 5068
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
Suite 1, Warringal Private Hospital, 216 Burgundy Street, Heidelberg VIC 3084
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
Suite 3, 140 Mounts Bay Road, Perth, WA 6000
Heart Failure due to mitral valve regurgitation
HighLife
To evaluate a new valve in patients with severe mitral regurgitation
St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150
Heart Failure Device
COAST
To evaluate a new heart failure sensing device in patients with heart failure
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Pericarditis
RHAPSODY
To evaluate a new medication for the treatment of recurrent pericarditis.
Unit 2 / 11 Gloucester Avenue, Berwick VIC 3806
Pericarditis
RHAPSODY
To evaluate a new medication for the treatment of recurrent pericarditis.
Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109
Pericarditis
RHAPSODY
To evaluate a new medication for the treatment of recurrent pericarditis.
Mater Private Clinic Suite 5.02 & 5.11, Level 5 550 Stanley Street South Brisbane QLD 4101
Pericarditis
RHAPSODY
To evaluate a new medication for the treatment of recurrent pericarditis.
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Cardiovascular disease and obesity
SELECT
To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Cardiovascular disease and obesity
SELECT
To evaluate if treatment with a new medication reduces the risk of cardiovascular disease in overweight or obese patients
Suite 103, Specialist Medical Centre West, Grand Blvd & Shenton Ave, Joondalup, WA, 6027
Heart Failure due to mitral valve regurgitation
MAVERIC
To evaluate a new valve in patients with severe mitral regurgitation.
St Andrew's Medical Centre Clinic, Level 2. 321 South Terrace, Adelaide, SA 5000
Heart Failure due to mitral valve regurgitation
MAVERIC
To evaluate a new valve in patients with severe mitral regurgitation.
284 Kensington Road, Leabrook, SA 5068
Heart Failure due to mitral valve regurgitation
MAVERIC
To evaluate a new valve in patients with severe mitral regurgitation.
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
Heart Failure due to mitral valve regurgitation
MAVERIC
To evaluate a new valve in patients with severe mitral regurgitation.
Suite 1, 1008 Doncaster Road, Doncaster East VIC 3109
Heart Failure due to mitral valve regurgitation
MAVERIC
To evaluate a new valve in patients with severe mitral regurgitation.
St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150
High Cholesterol
CLEAR
To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.
284 Kensington Road, Leabrook, SA 5068
High Cholesterol
CLEAR
To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.
Wesley Hospital Auchenflower (Cardiology)
Level 5, Suite 91 Sandford Jackson Building 30 Chasely Street Auchenflower QLD 4066
High Cholesterol
CLEAR
To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.
Joondalup – Shenton House (Cardiology)
Level 3, Shenton House, 57 Shenton Avenue, Joondalup, WA 6027
High Cholesterol
CLEAR
To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.
St John of God Wexford Medical Centre, Level 4, Suite 68-72, 3 Barry Marshall Parade, Murdoch, WA 6150
High Cholesterol
CLEAR
To evaluate if treatment with a new medication reduces the risk of heart attack in patients who have had complications related to taking statin medication.
Friendly Society Private Hospital (FSPH) Bundaberg
Floor 1, 19-23 Bingera Street, Bundaberg QLD 4670